REPORT ID 5204

EMEA (Europe, Middle East and Africa) Histone Deacetylase 6 Market Report 2017

Publish Date
20-Dec-17
Pages
118
Format
Electronic (PDF)

In this report, the EMEA Histone Deacetylase 6 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Histone Deacetylase 6 for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Histone Deacetylase 6 market competition by top manufacturers/players, with Histone Deacetylase 6 sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Celgene Corp
    Chong Kun Dang Pharmaceutical Corp
    Curis Inc
    HitGen LTD
    Kancera AB
    Karus Therapeutics Ltd
    Medivir AB
    Merck & Co Inc
    Millennium Pharmaceuticals Inc
    OnKure Inc
    Quimatryx SL
    Shuttle Pharmaceuticals LLC
    Sigma-Tau SpA
    SK Biopharmaceuticals Co Ltd

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Citarinostat
    CKD-504
    ACY-738
    HG-3001
    MPT-0B291
    Ricolinostat
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    CNS Lymphoma
    Colon Cancer
    Huntington Disease
    Inflammation
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Histone Deacetylase 6 Market Report 2017
1 Histone Deacetylase 6 Overview
    1.1 Product Overview and Scope of Histone Deacetylase 6
    1.2 Classification of Histone Deacetylase 6
        1.2.1 EMEA Histone Deacetylase 6 Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Histone Deacetylase 6 Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Citarinostat
        1.2.4 CKD-504
        1.2.5 ACY-738
        1.2.6 HG-3001
        1.2.7 MPT-0B291
        1.2.8 Ricolinostat
        1.2.9 Others
    1.3 EMEA Histone Deacetylase 6 Market by Application/End Users
        1.3.1 EMEA Histone Deacetylase 6 Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 CNS Lymphoma
        1.3.3 Colon Cancer
        1.3.4 Huntington Disease
        1.3.5 Inflammation
        1.3.6 Others
    1.4 EMEA Histone Deacetylase 6 Market by Region
        1.4.1 EMEA Histone Deacetylase 6 Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Histone Deacetylase 6 (2012-2022)
        1.5.1 EMEA Histone Deacetylase 6 Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Histone Deacetylase 6 Revenue and Growth Rate (2012-2022)

2 EMEA Histone Deacetylase 6 Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Histone Deacetylase 6 Market Competition by Players/Manufacturers
        2.1.1 EMEA Histone Deacetylase 6 Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Histone Deacetylase 6 Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Histone Deacetylase 6 Sale Price by Players (2012-2017)
    2.2 EMEA Histone Deacetylase 6 (Volume and Value) by Type/Product Category
        2.2.1 EMEA Histone Deacetylase 6 Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Histone Deacetylase 6 Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Histone Deacetylase 6 Sale Price by Type (2012-2017)
    2.3 EMEA Histone Deacetylase 6 (Volume) by Application
    2.4 EMEA Histone Deacetylase 6 (Volume and Value) by Region
        2.4.1 EMEA Histone Deacetylase 6 Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Histone Deacetylase 6 Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Histone Deacetylase 6 Sales Price by Region (2012-2017)

3 Europe Histone Deacetylase 6 (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Histone Deacetylase 6 Sales and Value (2012-2017)
        3.1.1 Europe Histone Deacetylase 6 Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Histone Deacetylase 6 Revenue and Growth Rate (2012-2017)
    3.2 Europe Histone Deacetylase 6 Sales and Market Share by Type
    3.3 Europe Histone Deacetylase 6 Sales and Market Share by Application
    3.4 Europe Histone Deacetylase 6 Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Histone Deacetylase 6 Sales Volume by Countries (2012-2017)
        3.4.2 Europe Histone Deacetylase 6 Revenue by Countries (2012-2017)
        3.4.3 Germany Histone Deacetylase 6 Sales and Growth Rate (2012-2017)
        3.4.4 France Histone Deacetylase 6 Sales and Growth Rate (2012-2017)
        3.4.5 UK Histone Deacetylase 6 Sales and Growth Rate (2012-2017)
        3.4.6 Russia Histone Deacetylase 6 Sales and Growth Rate (2012-2017)
        3.4.7 Italy Histone Deacetylase 6 Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Histone Deacetylase 6 Sales and Growth Rate (2012-2017)

4 Middle East Histone Deacetylase 6 (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Histone Deacetylase 6 Sales and Value (2012-2017)
        4.1.1 Middle East Histone Deacetylase 6 Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Histone Deacetylase 6 Revenue and Growth Rate (2012-2017)
    4.2 Middle East Histone Deacetylase 6 Sales and Market Share by Type
    4.3 Middle East Histone Deacetylase 6 Sales and Market Share by Application
    4.4 Middle East Histone Deacetylase 6 Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Histone Deacetylase 6 Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Histone Deacetylase 6 Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Histone Deacetylase 6 Sales and Growth Rate (2012-2017)
        4.4.4 Israel Histone Deacetylase 6 Sales and Growth Rate (2012-2017)
        4.4.5 UAE Histone Deacetylase 6 Sales and Growth Rate (2012-2017)
        4.4.6 Iran Histone Deacetylase 6 Sales and Growth Rate (2012-2017)

5 Africa Histone Deacetylase 6 (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Histone Deacetylase 6 Sales and Value (2012-2017)
        5.1.1 Africa Histone Deacetylase 6 Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Histone Deacetylase 6 Revenue and Growth Rate (2012-2017)
    5.2 Africa Histone Deacetylase 6 Sales and Market Share by Type
    5.3 Africa Histone Deacetylase 6 Sales and Market Share by Application
    5.4 Africa Histone Deacetylase 6 Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Histone Deacetylase 6 Sales Volume by Countries (2012-2017)
        5.4.2 Africa Histone Deacetylase 6 Revenue by Countries (2012-2017)
        5.4.3 South Africa Histone Deacetylase 6 Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Histone Deacetylase 6 Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Histone Deacetylase 6 Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Histone Deacetylase 6 Sales and Growth Rate (2012-2017)

6 EMEA Histone Deacetylase 6 Manufacturers/Players Profiles and Sales Data
    6.1 Celgene Corp
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Histone Deacetylase 6 Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Celgene Corp Histone Deacetylase 6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Chong Kun Dang Pharmaceutical Corp
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Histone Deacetylase 6 Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Chong Kun Dang Pharmaceutical Corp Histone Deacetylase 6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Curis Inc
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Histone Deacetylase 6 Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Curis Inc Histone Deacetylase 6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 HitGen LTD
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Histone Deacetylase 6 Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 HitGen LTD Histone Deacetylase 6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Kancera AB
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Histone Deacetylase 6 Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Kancera AB Histone Deacetylase 6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Karus Therapeutics Ltd
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Histone Deacetylase 6 Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Karus Therapeutics Ltd Histone Deacetylase 6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Medivir AB
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Histone Deacetylase 6 Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Medivir AB Histone Deacetylase 6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Merck & Co Inc
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Histone Deacetylase 6 Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Merck & Co Inc Histone Deacetylase 6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Millennium Pharmaceuticals Inc
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Histone Deacetylase 6 Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Millennium Pharmaceuticals Inc Histone Deacetylase 6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 OnKure Inc
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Histone Deacetylase 6 Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 OnKure Inc Histone Deacetylase 6 Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Quimatryx SL
    6.12 Shuttle Pharmaceuticals LLC
    6.13 Sigma-Tau SpA
    6.14 SK Biopharmaceuticals Co Ltd

7 Histone Deacetylase 6 Manufacturing Cost Analysis
    7.1 Histone Deacetylase 6 Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Histone Deacetylase 6

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Histone Deacetylase 6 Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Histone Deacetylase 6 Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Histone Deacetylase 6 Market Forecast (2017-2022)
    11.1 EMEA Histone Deacetylase 6 Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Histone Deacetylase 6 Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Histone Deacetylase 6 Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Histone Deacetylase 6 Price and Trend Forecast (2017-2022)
    11.2 EMEA Histone Deacetylase 6 Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Histone Deacetylase 6 Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Histone Deacetylase 6 Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Histone Deacetylase 6 Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Histone Deacetylase 6 Sales Forecast by Type (2017-2022)
    11.7 EMEA Histone Deacetylase 6 Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer